Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial

CP Skipper, KA Pastick, NW Engen… - Annals of internal …, 2020 - acpjournals.org
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
被引用次数：650 相关文章

Hydroxychloroquine in nonhospitalized adults with early COVID-19.

CP Skipper, KA Pastick, NW Engen, AS Bangdiwala… - 2020 - cabidigitallibrary.org
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial.

CP Skipper, KA Pastick, NW Engen… - Annals of Internal …, 2020 - europepmc.org
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

[引用][C] Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

CP Skipper, KA Pastick, NW Engen… - Annals of Internal …, 2020 - cir.nii.ac.jp
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士 …
[HTML] nih.gov

[HTML][HTML] Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

CP Skipper, KA Pastick, NW Engen… - Annals of Internal … - ncbi.nlm.nih.gov
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

CP Skipper, KA Pastick, NW Engen, AS Bangdiwala… - 2020 - escholarship.mcgill.ca
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

CP Skipper, KA Pastick, NS Engen… - Annals of Internal …, 2020 - experts.umn.edu
BACKGROUND: No effective oral therapy exists for early coronavirus disease 2019 (COVID-
19). OBJECTIVE: To investigate whether hydroxychloroquine could reduce COVID-19 …
[PDF] researchgate.net

[PDF][PDF] Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

CP Skipper, KA Pastick, NW Engen, AS Bangdiwala… - researchgate.net
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

CP Skipper, KA Pastick, NW Engen, AS Bangdiwala… - 2020 - pubmed.ncbi.nlm.nih.gov
Background No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective To investigate whether hydroxychloroquine could reduce COVID-19 severity in …

[引用][C] Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial.

CP Skipper, KA Pastick, NW Engen, AS Bangdiwala… - Annals of Internal Medicine, 2020